基于基因型的心律失常性心肌病临床病理新分类及其对疾病进展的启示
本研究对60例移植切除的AC心脏进行标准病理检查,结合临床、基因型及CMR资料,通过纤维脂肪分布无监督聚类构建4个亚型。Cluster 1主要为桥粒突变(除desmoplakin外)且移植年龄早,符合经典「桥粒心肌病」;胸前导联QRS电压是右室残留心肌的独立指标,并在验证队列(n=92)中可预测死亡/移植事件。
要点
- 基于纤维脂肪分布的无监督聚类将AC分为4个临床病理亚型。
- Cluster 1以桥粒突变(除desmoplakin外)为主,移植年龄早,可定义为桥粒心肌病。
- 胸前导联QRS电压是右室残留心肌的独立指标,可预测AC患者死亡/移植事件。
核心结论
- 本研究提出一种具有不同遗传背景、提示不同潜在发病机制的AC新分类。
- Cluster 1在基因型和临床病理上具有独特性,可定义为「桥粒心肌病」。
- 胸前导联QRS振幅是反映右室重构的独立指标,可能预测AC患者的移植/死亡事件。
研究设计与样本
- 收集60例移植切除的AC心脏,进行标准病理检查。
- 评估患者临床特征、基因型及心脏磁共振成像表现,并结合病理特征。
- 对每颗心脏6个代表性切面行Masson染色,采用数字病理结合图像分割计算心肌、纤维化及脂肪组织分布。
- 基于纤维脂肪分布构建含4个亚型的无监督聚类。
- 在多变量回归中分析胸前导联QRS电压与右室残留心肌的关系,并在验证队列(n=92)中验证其预测死亡和移植事件的能力。
主要发现
- Cluster 1患者主要携带桥粒突变(除desmoplakin外),移植年龄早,符合经典「桥粒心肌病」。
- Cluster 2大多为非桥粒突变,表现为右室区域性纤维脂肪替代。
- Cluster 3表现为平行进展,包括desmoplakin突变患者。
- Cluster 4为典型左优势型AC,其遗传背景尚不明确。
- 多变量回归分析显示胸前导联QRS电压是右室残留心肌的独立指标,并在验证队列(n=92)中验证可预测死亡和移植事件。
临床怎么用
- 可依据纤维脂肪分布聚类将AC分为4个亚型,辅助理解不同遗传背景与疾病进展。
- 对桥粒突变(除desmoplakin外)且移植年龄早的患者可识别为经典桥粒心肌病。
- 胸前导联QRS电压可作为反映右室重构的独立指标,用于预测AC患者移植/死亡事件。
局限性
- Cluster 4左优势型AC的遗传背景尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Arrhythmogenic cardiomyopathy (AC) shows large heterogeneity in its clinical, genetic, and pathological presentation. This study aims to provide a comprehensive atlas of end-stage AC and illustrate the relationships among clinical characteristics, genotype, and pathological profiles of patients with this disease. METHODS AND RESULTS: We collected 60 explanted AC hearts and performed standard pathology examinations. The clinical characteristics of patients, their genotype and cardiac magnetic resonance imaging findings were assessed along with pathological characteristics. Masson staining of six representative sections of each heart were performed. Digital pathology combined with image segmentation was developed to calculate distribution of myocardium, fibrosis, and adipose tissue. An unsupervised clustering based on fibrofatty distribution containing four subtypes was constructed. Patients in Cluster 1 mainly carried desmosomal mutations (except for desmoplakin) and were subjected to transplantation at early age; this group was consistent with classical 'desmosomal cardiomyopathy'. Cluster 2 mostly had non-desmosomal mutations and showed regional fibrofatty replacement in right ventricle. Patients in Cluster 3 showed parallel progression, and included patients with desmoplakin mutations. Cluster 4 is typical left-dominant AC, although the genetic background of these patients is not yet clear. Multivariate regression analysis revealed precordial QRS voltage as an independent indicator of the residual myocardium of right ventricle, which was validated in predicting death and transplant events in the validation cohort (n = 92). CONCLUSION: This study provides a novel classification of AC with distinct genetic backgrounds indicating different potential pathogenesis. Cluster 1 is distinct in genotype and clinicopathology and can be defined as 'desmosomal cardiomyopathy'. Precordial QRS amplitude is an independent indicator reflecting the right ventricular remodelling, which may be able to predict transplant/death events for AC patients.
引用
- Chen L, Song J, Chen X, et al. A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression. Eur Heart J. 2019. PMID: 30945739. doi:10.1093/eurheartj/ehz172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。